Jacques Lepercq
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jacques Lepercq has a total of 115 co-authors. Here are the top co-authors by number of shared publications:
François Goffinet
Maternité Port-Royal, Hôpital Cochin, GHU Paris Centre, AP-HP, 75014 Paris, France; Université de Paris Cité, 75006 Paris, France
5 shared publicationsJ. Timsit
Department of diabetology, DHU AUTHORS, Paris Descartes university, Cochin hospital, Assistance publique-Hôpitaux de Paris, 75014 Paris, France
3 shared publicationsC Francoual
2 shared publications- Dominique Hubert
Respiratory Medicine and National Cystic Fibrosis Reference Center, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
2 shared publications José Timsit
Department of Obstetrics and Gynecology of Port Royal, Department of Diabetology, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, France; Paris Descartes University, Sorbonne Paris Cité, and INSERM Unit 953, Epidemiological Research Unit on Perinatal Health and Women's Health, Paris, France
2 shared publications- Sylvie Hauguel-De Mouzon
Center for Reproductive Health, MetroHealth Medical Center, Case Western Reserve University School of Medicine, 2500 MetroHealth Dr., Cleveland, OH, 44109-1998, USA.
2 shared publications
Latest Publications
- 19 February 2025
- Published by Springer Nature in Diabetologia
- Vol. 68 (5) , 981-992
Pregnancy and neonatal outcomes in women with GCK-MODY: an observational study based on standardised insulin modalities
Aims/hypothesis The management of GCK-MODY during pregnancy remains challenging. We evaluated the impact on pregnancy and neonatal outcomes of two standardised insulin strategies. Methods In this prospective observational study, participants chose (in agreement with their physician) to be treated with insulin either when maternal capillary blood glucose (CBG) ≥ thresholds for gestational diabetes (5.3 mmol/l before or 6.7 mmol/l 2 h after meals) (MG group) or when fetal abdominal circumference ≥75th percentile (FG group). In the FG group, insulin was also initiated if CBG ≥ safety levels (6.7 mmol/l before meals or 11.1 mmol/l 2 h after meals). Data on glycaemic management, modalities and timing of insulin therapy and maternal and neonatal outcomes were recorded. Results In the MG group (n=25), insulin was initiated more frequently (100% vs 75%, p=0.01) and earlier (p=0.001), with lower CBG and more frequent hypoglycaemic episodes compared with the FG group (n=21). However, there were no differences in pregnancy and neonatal outcomes. In the total cohort, the rate of large for gestational age (LGA) neonates, preterm deliveries and Caesarean sections was 22.2%, 2.2% and 40%, respectively. The rate of LGA was 0% among the neonates with the GCK variant vs 36% in those without (p=0.005). There were no associations between LGA and pregnancy characteristics, insulin therapy strategy or glycaemic management. Conclusions/interpretation In our study, the rate of LGA primarily depended on the fetal GCK genotype rather than the treatment strategy or glycaemic management. Our results suggest that a standardised strategy based on ultrasound monitoring of fetal growth and glycaemic safety thresholds, leading to delayed insulin initiation, offers a good fetal prognosis and minimises the risk of maternal hypoglycaemia. Trial registration ClinTrials.gov NCT02556840. Graphical Abstract
- 19 February 2025
- Published by Springer Nature in Diabetologia
- Vol. 68 (5) , 981-992
Pregnancy and neonatal outcomes in women with GCK-MODY: an observational study based on standardised insulin modalities
Aims/hypothesis The management of GCK-MODY during pregnancy remains challenging. We evaluated the impact on pregnancy and neonatal outcomes of two standardised insulin strategies. Methods In this prospective observational study, participants chose (in agreement with their physician) to be treated with insulin either when maternal capillary blood glucose (CBG) ≥ thresholds for gestational diabetes (5.3 mmol/l before or 6.7 mmol/l 2 h after meals) (MG group) or when fetal abdominal circumference ≥75th percentile (FG group). In the FG group, insulin was also initiated if CBG ≥ safety levels (6.7 mmol/l before meals or 11.1 mmol/l 2 h after meals). Data on glycaemic management, modalities and timing of insulin therapy and maternal and neonatal outcomes were recorded. Results In the MG group (n=25), insulin was initiated more frequently (100% vs 75%, p=0.01) and earlier (p=0.001), with lower CBG and more frequent hypoglycaemic episodes compared with the FG group (n=21). However, there were no differences in pregnancy and neonatal outcomes. In the total cohort, the rate of large for gestational age (LGA) neonates, preterm deliveries and Caesarean sections was 22.2%, 2.2% and 40%, respectively. The rate of LGA was 0% among the neonates with the GCK variant vs 36% in those without (p=0.005). There were no associations between LGA and pregnancy characteristics, insulin therapy strategy or glycaemic management. Conclusions/interpretation In our study, the rate of LGA primarily depended on the fetal GCK genotype rather than the treatment strategy or glycaemic management. Our results suggest that a standardised strategy based on ultrasound monitoring of fetal growth and glycaemic safety thresholds, leading to delayed insulin initiation, offers a good fetal prognosis and minimises the risk of maternal hypoglycaemia. Trial registration ClinTrials.gov NCT02556840. Graphical Abstract
- 4 May 2024
- Published by Elsevier in Anesthésie & Réanimation
- Vol. 10 (3) , 283-288
Morts maternelles par accident vasculaire cérébral en France 2016–2018
- 4 May 2024
- Published by Elsevier in Anesthésie & Réanimation
- Vol. 10 (3) , 283-288
Morts maternelles par accident vasculaire cérébral en France 2016–2018
- Open Access
- 17 February 2024
- Published by Elsevier in Gynécologie Obstétrique Fertilité & Sénologie
- Vol. 52 (4) , 259-262
Mortalité maternelle par accident vasculaire cérébral en France 2016–2018
- 17 February 2024
- Published by Elsevier in Gynécologie Obstétrique Fertilité & Sénologie
- Vol. 52 (4) , 259-262
Open AccessMortalité maternelle par accident vasculaire cérébral en France 2016–2018
- 6 January 2024
- Published by Elsevier in Gynécologie Obstétrique Fertilité & Sénologie
- Vol. 52 (2) , 109-113
Quelle réponse apporter à un refus obstiné de soins lors de l’accouchement ?
- 6 January 2024
- Published by Elsevier in Gynécologie Obstétrique Fertilité & Sénologie
- Vol. 52 (2) , 109-113
Quelle réponse apporter à un refus obstiné de soins lors de l’accouchement ?
- Open Access
- 28 June 2023
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 102 (8) , 1092-1099
Meconium‐stained amniotic fluid and neonatal morbidity in nulliparous patients with prolonged pregnancy
Introduction: Our objective was to study the strength of the association between meconium‐stained amniotic fluid and severe morbidity among neonates of nulliparas with prolonged pregnancies.Material and methods: This was a secondary analysis of the NOCETER randomized trial that took place between 2009 and 2012 in which 11 French maternity units included 1373 nulliparas at 41+0 weeks of gestation onwards with a single live fetus in cephalic presentation. This analysis excluded patients with a cesarean delivery before labor and those with bloody amniotic fluid or of unreported consistency. The principal end point was a composite criterion of severe neonatal morbidity (neonatal death, 5‐minute Apgar p < 0.001; adjusted relative risk [aRR] 3.3, 95% confidence interval [CI] 1.7–6.3), but those of patients with thin amniotic fluid did not (3.1% vs. 2.2%; p = 0.50; aRR 1.0, 95% CI, 0.4–2.7).Conclusions: Among nulliparas at 41+0 weeks onwards, only thick meconium‐stained amniotic fluid is associated with a higher rate of severe neonatal morbidity.
- 28 June 2023
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 102 (8) , 1092-1099
Open AccessMeconium‐stained amniotic fluid and neonatal morbidity in nulliparous patients with prolonged pregnancy
Introduction: Our objective was to study the strength of the association between meconium‐stained amniotic fluid and severe morbidity among neonates of nulliparas with prolonged pregnancies.Material and methods: This was a secondary analysis of the NOCETER randomized trial that took place between 2009 and 2012 in which 11 French maternity units included 1373 nulliparas at 41+0 weeks of gestation onwards with a single live fetus in cephalic presentation. This analysis excluded patients with a cesarean delivery before labor and those with bloody amniotic fluid or of unreported consistency. The principal end point was a composite criterion of severe neonatal morbidity (neonatal death, 5‐minute Apgar p < 0.001; adjusted relative risk [aRR] 3.3, 95% confidence interval [CI] 1.7–6.3), but those of patients with thin amniotic fluid did not (3.1% vs. 2.2%; p = 0.50; aRR 1.0, 95% CI, 0.4–2.7).Conclusions: Among nulliparas at 41+0 weeks onwards, only thick meconium‐stained amniotic fluid is associated with a higher rate of severe neonatal morbidity.
- 24 June 2023
- Published by Elsevier in Journal of Gynecology Obstetrics and Human Reproduction
- Vol. 52 (8) , 102626
Risk of disseminated intravascular coagulation in postpartum hemorrhage associated with intrauterine infection
- 24 June 2023
- Published by Elsevier in Journal of Gynecology Obstetrics and Human Reproduction
- Vol. 52 (8) , 102626
Risk of disseminated intravascular coagulation in postpartum hemorrhage associated with intrauterine infection
- 3 November 2022
- Published by Elsevier in Journal of Gynecology Obstetrics and Human Reproduction
- Vol. 52 (1) , 102498
Risk factors for hypoxic-ischemic encephalopathy or neonatal death in placental abruption
- 3 November 2022
- Published by Elsevier in Journal of Gynecology Obstetrics and Human Reproduction
- Vol. 52 (1) , 102498
Risk factors for hypoxic-ischemic encephalopathy or neonatal death in placental abruption
- 1 December 2021
- Published by Elsevier in Journal of Gynecology Obstetrics and Human Reproduction
- Vol. 50 (10) , 102194
Factors associated with a latency < 7 days after preterm premature rupture of membranes between 22 and 32 weeks of gestation in singleton pregnancies
- 1 December 2021
- Published by Elsevier in Journal of Gynecology Obstetrics and Human Reproduction
- Vol. 50 (10) , 102194
Factors associated with a latency < 7 days after preterm premature rupture of membranes between 22 and 32 weeks of gestation in singleton pregnancies
- 1 October 2021
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 76 (10) , 589-591
Fetal Heart Rate Nadir During Bradycardia and Umbilical Artery Acidemia at Birth
(Abstracted from Acta Obstet Gynecol Scand 2021;100:964–970) Although rare, fetal bradycardia caused by cord prolapse, placental abruption, or uterine rupture is associated with sudden and prolonged deceleration of the fetal heart rate. When this occurs, there is an association between the bradycardia-to-delivery interval and umbilical artery pH at birth.
- 1 October 2021
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 76 (10) , 589-591
Fetal Heart Rate Nadir During Bradycardia and Umbilical Artery Acidemia at Birth
(Abstracted from Acta Obstet Gynecol Scand 2021;100:964–970) Although rare, fetal bradycardia caused by cord prolapse, placental abruption, or uterine rupture is associated with sudden and prolonged deceleration of the fetal heart rate. When this occurs, there is an association between the bradycardia-to-delivery interval and umbilical artery pH at birth.
- 1 May 2021
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 260, 118-123
Risk factors of relaparotomy for intra-abdominal hemorrhage after cesarean delivery
- 1 May 2021
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 260, 118-123
Risk factors of relaparotomy for intra-abdominal hemorrhage after cesarean delivery